Targeting SALL4 by entinostat in lung cancer

The overall survival of lung cancer patients remains dismal despite the availability of targeted therapies. Oncofetal protein SALL4 is a novel cancer target. We herein report that SALL4 was aberrantly expressed in a subset of lung cancer patients with poor survival. SALL4 silencing by RNA interferen...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncotarget
Main Authors: Yong, Kol Jia, Li, Ailing, Ou, Wen-Bin, Hong, Clarice Kit Yee, Zhao, Wenxiu, Wang, Fei, Tatetsu, Hiro, Yan, Benedict, Qi, Lihua, Fletcher, Jonathan A., Yang, Henry, Soo, Ross, Tenen, Daniel G., Chai, Li
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2016
Teme:
Research Paper
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5342750/
https://ncbi.nlm.nih.gov/pubmed/27705911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.12251
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki